Legend Biotech (LEGN) Profit After Tax (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Profit After Tax data on file, last reported at -$54.3 million in Q1 2026.

• Quarterly Profit After Tax rose 46.24% year-over-year to -$54.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$188.5 million (up 13.59% YoY) and the FY2025 annual result came in at $296.8 million, up 267.68% from the prior year.
• Profit After Tax retreated to -$54.3 million in Q1 2026, from $30.9 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $30.9 million in Q4 2025 to a low of -$199.1 million in Q2 2023.
• A 5-year average of -$74.9 million and a median of -$62.2 million in 2023 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2022 — Profit After Tax tumbled 32288.91% — and 2024, when it soared 18329.78%.
• Tracing LEGN's Profit After Tax over 5 years: stood at -$135.9 million in 2022, then surged by 99.89% to -$144818.0 in 2023, then soared by 18329.78% to $26.4 million in 2024, then increased by 17.05% to $30.9 million in 2025, then plunged by 275.73% to -$54.3 million in 2026.
• The last three Profit After Tax figures came in at -$54.3 million (Q1 2026), $30.9 million (Q4 2025), and -$39.7 million (Q3 2025), per Business Quant data.